Status:
COMPLETED
Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborating Sponsors:
Sunnybrook Health Sciences Centre
Liverpool Women's NHS Foundation Trust
Conditions:
Pulmonary Hypertension
Infant, Premature
Eligibility:
All Genders
14+ years
Brief Summary
Chronic pulmonary hypertension (cPHT) is a serious cardiopulmonary disorder that causes low oxygen levels in the blood, difficulty in breathing and ultimately heart failure. Newborn babies born extrem...
Detailed Description
This is a multi-centre prospective observational study to develop new quantitative echocardiography diagnostic criteria sensitive to identify the presence of chronic pulmonary hypertension early in po...
Eligibility Criteria
Inclusion
- Gestational age at birth ≤26+6/7 and/or birth weight \<1000g
- Alive at two weeks of postnatal age
- Infant cleared by the clinical team for approach
Exclusion
- Known major congenital and/or genetic anomaly
- Congenital heart defects (CHD) except patent ductus arteriosus (PDA), patent foramen ovale (PFO), peripheral pulmonary artery stenosis and small (\< 3 mm in diameter) ventricular septal defects
- Any condition which, in the opinion of the investigator, would preclude enrollment
Key Trial Info
Start Date :
August 31 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04402645
Start Date
August 31 2017
End Date
April 1 2024
Last Update
June 14 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Health Care
Iowa City, Iowa, United States, 52242
2
BC Women's Hospital & Health Centre
Vancouver, British Columbia, Canada, V6H 3N1
3
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
4
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5